SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LindyBill who wrote (75852)10/8/2004 7:24:10 PM
From: Alastair McIntosh  Read Replies (3) of 793818
 
Of course drug ads benefit the bottom of line of drug companies. Unfortunately they add to the use of pharmaceuticals that are almost useless if not actually harmful.

Consider two of the more egregious examles, statins and cox-2 inhibitors. Both are heavily advertised multi-billion dollar drugs. Statins contribute little or nothing to wellness and cox-2 inhibitors are usually no better that other NSAIDS available at a fraction of the cost.

Statins produce at best a tiny decrease in long term mortality and even this decrease may be the result of selection bias in the research. Cox-2 inhibitors are widely prescribed for arthritis but should only be used for the 10% of arthritis patients suffering from ulcers or digestive-tract problems. Ibuprofen or naproxene work as well at a much lower cost.

Prohibiting "direct to user" drug advertising would be a huge benefit to consumers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News